AAH Pharmaceuticals Ltd, a leading name in the pharmaceutical distribution industry, is headquartered in Great Britain. Established in 1997, the company has grown to become a key player in the supply of healthcare products and services across the UK and Ireland. AAH Pharmaceuticals focuses on delivering a comprehensive range of pharmaceuticals, medical supplies, and healthcare solutions, catering to the needs of pharmacies, hospitals, and healthcare professionals. With a commitment to quality and efficiency, AAH Pharmaceuticals stands out for its robust logistics network and innovative supply chain solutions. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. Recognised for its reliability and customer-centric approach, AAH Pharmaceuticals continues to play a vital role in supporting the healthcare sector, ensuring that essential medicines and products are readily available to those who need them most.
How does AAH Pharmaceuticals Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AAH Pharmaceuticals Ltd's score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AAH Pharmaceuticals Ltd, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company has not disclosed any absolute emissions figures, including Scope 1, 2, or 3 emissions, nor has it set any documented reduction targets or climate pledges. As a current subsidiary, AAH Pharmaceuticals Ltd may inherit climate commitments and data from its parent organization. However, no specific initiatives or targets have been identified from the corporate family relationship at this time. The absence of emissions data and reduction initiatives suggests that AAH Pharmaceuticals Ltd is still in the early stages of formalising its climate strategy. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate commitments and transparent reporting practices. AAH Pharmaceuticals Ltd will need to align with these industry standards to enhance its sustainability profile and meet stakeholder expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
AAH Pharmaceuticals Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.